BACKGROUND: Aspects of infant antibiotic exposure and its association with asthma development have been variably explored. We aimed to evaluate comprehensively and simultaneously the impact of dose, timing, and type of infant antibiotic use on the risk of childhood asthma. METHODS: Singleton, term-birth, non-low-birth-weight, and otherwise healthy children enrolled in the Tennessee Medicaid Program were included. Infant antibiotic use and childhood asthma diagnosis were ascertained from prescription fills and healthcare encounter claims. We examined the association using multivariable logistic regression models. RESULTS: Among 152 622 children, 79% had at least 1 antibiotic prescription fill during infancy. Infant antibiotic use was associated with increased odds of childhood asthma in a dose-dependent manner, with a 20% increase in odds (adjusted odds ratio [aOR], 1.20 [95% confidence interval {CI}, 1.19-1.20]) for each additional antibiotic prescription filled. This significant dose-dependent relationship persisted after additionally controlling for timing and type of the antibiotics. Infants who had broad-spectrum-only antibiotic fills had increased odds of developing asthma compared with infants who had narrow-spectrum-only fills (aOR, 1.10 [95% CI, 1.05-1.19]). There was no significant association between timing, formulation, anaerobic coverage, and class of antibiotics and childhood asthma. CONCLUSIONS: We found a consistent dose-dependent association between antibiotic prescription fills during infancy and subsequent development of childhood asthma. Our study adds important insights into specific aspects of infant antibiotic exposure. Clinical decision making regarding antibiotic stewardship and prevention of adverse effects should be critically assessed prior to use during infancy.
BACKGROUND: Aspects of infant antibiotic exposure and its association with asthma development have been variably explored. We aimed to evaluate comprehensively and simultaneously the impact of dose, timing, and type of infant antibiotic use on the risk of childhood asthma. METHODS: Singleton, term-birth, non-low-birth-weight, and otherwise healthy children enrolled in the Tennessee Medicaid Program were included. Infant antibiotic use and childhood asthma diagnosis were ascertained from prescription fills and healthcare encounter claims. We examined the association using multivariable logistic regression models. RESULTS: Among 152 622 children, 79% had at least 1 antibiotic prescription fill during infancy. Infant antibiotic use was associated with increased odds of childhood asthma in a dose-dependent manner, with a 20% increase in odds (adjusted odds ratio [aOR], 1.20 [95% confidence interval {CI}, 1.19-1.20]) for each additional antibiotic prescription filled. This significant dose-dependent relationship persisted after additionally controlling for timing and type of the antibiotics. Infants who had broad-spectrum-only antibiotic fills had increased odds of developing asthma compared with infants who had narrow-spectrum-only fills (aOR, 1.10 [95% CI, 1.05-1.19]). There was no significant association between timing, formulation, anaerobic coverage, and class of antibiotics and childhood asthma. CONCLUSIONS: We found a consistent dose-dependent association between antibiotic prescription fills during infancy and subsequent development of childhood asthma. Our study adds important insights into specific aspects of infant antibiotic exposure. Clinical decision making regarding antibiotic stewardship and prevention of adverse effects should be critically assessed prior to use during infancy.
Authors: Yael R Nobel; Laura M Cox; Francis F Kirigin; Nicholas A Bokulich; Shingo Yamanishi; Isabel Teitler; Jennifer Chung; Jiho Sohn; Cecily M Barber; David S Goldfarb; Kartik Raju; Sahar Abubucker; Yanjiao Zhou; Victoria E Ruiz; Huilin Li; Makedonka Mitreva; Alexander V Alekseyenko; George M Weinstock; Erica Sodergren; Martin J Blaser Journal: Nat Commun Date: 2015-06-30 Impact factor: 14.919
Authors: Guillermo V Sanchez; Rebecca M Roberts; Alison P Albert; Darcia D Johnson; Lauri A Hicks Journal: Emerg Infect Dis Date: 2014-12 Impact factor: 6.883
Authors: Elizabeth T Rogawski; James A Platts-Mills; Jessica C Seidman; Sushil John; Mustafa Mahfuz; Manjeswori Ulak; Sanjaya K Shrestha; Sajid Bashir Soofi; Pablo Penataro Yori; Estomih Mduma; Erling Svensen; Tahmeed Ahmed; Aldo Am Lima; Zulfiqar A Bhutta; Margaret N Kosek; Dennis R Lang; Michael Gottlieb; Anita Km Zaidi; Gagandeep Kang; Pascal O Bessong; Eric R Houpt; Richard L Guerrant Journal: Bull World Health Organ Date: 2016-11-03 Impact factor: 9.408
Authors: Pingsheng Wu; Amy S Feldman; Christian Rosas-Salazar; Kristina James; Gabriel Escobar; Tebeb Gebretsadik; Sherian Xu Li; Kecia N Carroll; Eileen Walsh; Edward Mitchel; Suman Das; Rajesh Kumar; Chang Yu; William D Dupont; Tina V Hartert Journal: PLoS One Date: 2016-03-22 Impact factor: 3.240
Authors: Christine C Johnson; Suzanne L Havstad; Dennis R Ownby; Christine L M Joseph; Alexandra R Sitarik; Jocelyn Biagini Myers; Tebeb Gebretsadik; Tina V Hartert; Gurjit K Khurana Hershey; Daniel J Jackson; Robert F Lemanske; Lisa J Martin; Edward M Zoratti; Cynthia M Visness; Patrick H Ryan; Diane R Gold; Fernando D Martinez; Rachel L Miller; Christine M Seroogy; Anne L Wright; James E Gern Journal: J Allergy Clin Immunol Date: 2021-05-06 Impact factor: 10.793
Authors: Laura Toivonen; Linnea Schuez-Havupalo; Sinikka Karppinen; Matti Waris; Kristi L Hoffman; Carlos A Camargo; Kohei Hasegawa; Ville Peltola Journal: Clin Infect Dis Date: 2021-05-04 Impact factor: 9.079
Authors: Alexandros Rovas; Irina Osiaevi; Konrad Buscher; Jan Sackarnd; Phil-Robin Tepasse; Manfred Fobker; Joachim Kühn; Stephan Braune; Ulrich Göbel; Gerold Thölking; Andreas Gröschel; Hermann Pavenstädt; Hans Vink; Philipp Kümpers Journal: Angiogenesis Date: 2020-10-14 Impact factor: 10.658